Pyruvate Kinase Deficiency
Overview
Plain-Language Overview
Pyruvate Kinase Deficiency is a rare inherited disorder that affects the red blood cells, which are responsible for carrying oxygen throughout the body. This condition causes a shortage of a key enzyme called pyruvate kinase, which is important for producing energy in red blood cells. Without enough energy, these cells break down too early, leading to a type of anemia called hemolytic anemia. People with this disorder may experience symptoms like fatigue, pale skin, and an increased heart rate due to the low oxygen levels. The disease mainly impacts the blood and can cause complications related to the body's ability to transport oxygen efficiently.
Clinical Definition
Pyruvate Kinase Deficiency is an autosomal recessive disorder characterized by a deficiency of the pyruvate kinase enzyme in erythrocytes, resulting in impaired glycolysis and decreased ATP production. This energy deficit leads to premature destruction of red blood cells, causing chronic hemolytic anemia. The condition is caused by mutations in the PKLR gene, which encodes the pyruvate kinase enzyme. Clinically, patients present with jaundice, splenomegaly, and varying degrees of anemia from mild to severe. The disease is significant due to its impact on oxygen delivery and potential complications such as gallstones and iron overload. Diagnosis and management require understanding the underlying enzymatic defect and its hematologic consequences.